Author:
Er Tze-Kiong,Chen Chih-Chieh,Liu Yen-Yi,Chang Hui-Chiu,Chien Yin-Hsiu,Chang Jan-Gowth,Hwang Jenn-Kang,Jong Yuh-Jyh
Abstract
Abstract
Background
Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is an autosomal recessive disease caused by the defects in the mitochondrial electron transfer system and the metabolism of fatty acids. Recently, mutations in electron transfer flavoprotein dehydrogenase (ETFDH) gene, encoding electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) have been reported to be the major causes of riboflavin-responsive MADD. To date, no studies have been performed to explore the functional impact of these mutations or their mechanism of disrupting enzyme activity.
Results
High resolution melting (HRM) analysis and sequencing of the entire ETFDH gene revealed a novel mutation (p.Phe128Ser) and the hotspot mutation (p.Ala84Thr) from a patient with MADD. According to the predicted 3D structure of ETF:QO, the two mutations are located within the flavin adenine dinucleotide (FAD) binding domain; however, the two residues do not have direct interactions with the FAD ligand. Using molecular dynamics (MD) simulations and normal mode analysis (NMA), we found that the p.Ala84Thr and p.Phe128Ser mutations are most likely to alter the protein structure near the FAD binding site as well as disrupt the stability of the FAD binding required for the activation of ETF:QO. Intriguingly, NMA revealed that several reported disease-causing mutations in the ETF:QO protein show highly correlated motions with the FAD-binding site.
Conclusions
Based on the present findings, we conclude that the changes made to the amino acids in ETF:QO are likely to influence the FAD-binding stability.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Frerman FE, Goodman SI: Defects of electron transfer flavoprotein and electron transfer flavoprotein-ubiquinone oxidoreductase: glutaric aciduria type II. In The metabolic and molecular bases of inherited disease. 8th edition. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B. New York: McGraw-Hill; 2001:2357–2365.
2. Gregersen N, Kolvraa S, Rasmussen K, Christensen E, Brandt NJ, Ebbesen F, Hansen FH: Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II. Journal of Inherited Metabolic Disease 1981, 3(3):67–72.
3. Rhead W, Roettger V, Marshall T, Amendt B: Multiple acyl-coenzyme A dehydrogenation disorder responsive to riboflavin - substrate oxidation, flavin metabolism, and flavoenzyme activities in fibroblasts. Pediatric Research 1993, 33(2):129–135. 10.1203/00006450-199302000-00008
4. Vergani L, Barile M, Angelini C, Burlina AB, Nijtmans L, Freda MP, Brizio C, Zerbetto E, Dabbeni-Sala F: Riboflavin therapy - Biochemical heterogeneity in two adult lipid storage myopathies. Brain 1999, 122: 2401–2411. 10.1093/brain/122.12.2401
5. Olsen RKJ, Olpin SE, Andresen BS, Miedzybrodzka ZH, Pourfarzam M, Merinero B, Frerman FE, Beresford MW, Dean JCS, Cornelius N, et al.: ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 2007, 130: 2045–2054. 10.1093/brain/awm135
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献